SCHEMBL29840539

SCHEMBL29840539

COCCCOc1cc(CC(N)C(C)C)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 19/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18425645 1.00 REN (0.54) REN
SCHEMBL16930132 1.00 REN (0.54) REN
SCHEMBL17732239 0.89 SIGMAR1 (0.52) REN
SCHEMBL18457751 0.88 REN (0.53) REN
SCHEMBL16973552 0.86 REN (0.52) REN
SCHEMBL2738334 0.86 ALOX15 (0.55) REN
SCHEMBL14114916 0.86 ALOX15 (0.55) REN
SCHEMBL16930224 0.85 ALOX15 (0.59)
SCHEMBL18458926 0.85 FOS (0.52) REN
SCHEMBL16929880 0.85 REN (0.42) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715624-B Novel therapeutic agents for the treatment of HBV infection 广州麓鹏制药有限公司 2022-08-16 CN disclosed